
doi: 10.1002/mds.25147
pmid: 22976901
AbstractBackground:Autosomal dominant dopa‐responsive dystonia (AD‐DRD) is caused by a biochemical defect primarily resulting from guanosine triphosphate cyclohydrolase 1 gene (GCH1) mutations. Few families have been reported without mutations in GCH1.Methods:Genome‐wide linkage analysis and positional cloning to identify the genetic defect in a Belgian AD‐DRD family was carried out.Results and Conclusion:In this study, we report on the identification and characterization of a novel 24‐kb deletion spanning exon 1 and the 5′ regulatory region of GCH1 causing a wide spectrum of motor and nonmotor symptoms in a large Belgian AD‐DRD family. This large‐scale deletion of regulatory sequences leads to decreased GCH1 activity in all carriers, most probably resulting from allelic loss of transcription. We mapped the breakpoints of this deletion to the nucleotide level, allowing the development of a straightforward polymerase chain reaction assay for fast, efficient detection of this large deletion, which will prove valuable for preimplantation genetic diagnosis. © 2012 Movement Disorder Society
Adult, Male, Genetic Linkage, Dopamine Agents, FREQUENCY, DISEASE, Levodopa, Young Adult, Belgium, Sequence Deletion/genetics, large deletion, LINKAGE, PROGRAM, I GENE, Humans, copy number variant, GTP Cyclohydrolase, Promoter Regions, Genetic, Dystonia/drug therapy, Biology, MUTATION, dopa-responsive dystonia, Sequence Deletion, Family Health, promoter, Levodopa/therapeutic use, Chromosome Mapping, DRD, Middle Aged, Genetic linkage, Promoter Regions, Genetic/genetics, FAMILY, DEFICIENCY, Dystonia, Dopamine Agents/therapeutic use, young adult, Female, Human medicine, genome-wide linkage analysis, GTP Cyclohydrolase/genetics, GCH1, Genome-Wide Association Study
Adult, Male, Genetic Linkage, Dopamine Agents, FREQUENCY, DISEASE, Levodopa, Young Adult, Belgium, Sequence Deletion/genetics, large deletion, LINKAGE, PROGRAM, I GENE, Humans, copy number variant, GTP Cyclohydrolase, Promoter Regions, Genetic, Dystonia/drug therapy, Biology, MUTATION, dopa-responsive dystonia, Sequence Deletion, Family Health, promoter, Levodopa/therapeutic use, Chromosome Mapping, DRD, Middle Aged, Genetic linkage, Promoter Regions, Genetic/genetics, FAMILY, DEFICIENCY, Dystonia, Dopamine Agents/therapeutic use, young adult, Female, Human medicine, genome-wide linkage analysis, GTP Cyclohydrolase/genetics, GCH1, Genome-Wide Association Study
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
